minibaccarattable| Fuxiang Pharmaceutical (300497.SZ): The subsidiary obtained environmental assessment reply of 200,000 tons of microbial protein and comprehensive utilization of resources (Phase I)

Gronghui April 11, Fuxiang Pharmaceutical (300497minibaccarattable.SZ) announced that recently, Jiangxi Fuxiang Biotechnology Co., Ltd.(hereinafter referred to as "Fuxiang Biology"), a holding subsidiary of Jiangxi Fuxiang Pharmaceutical Co., Ltd., was issued by Ecological Environment Bureau of High-tech Zone of Jingdezhen CityminibaccarattableEnvironmental Impact Report of Jiangxi Fuxiang Biotechnology Co., Ltd.minibaccarattableReply (Jing Gaoxin Huan Zi [2024] No.8).

The reply agreed that Fuxiang Bio-construction of 200,000 tons of microbial protein and comprehensive utilization of resources project (Phase I), and requires Fuxiang Bio-use cleaner production technology to reduce pollutants, in the engineering design, construction and production process must seriously implement the environmental protection measures and requirements put forward in the environmental impact report.

Tags:

Prev: onlinecasinofreeplaynodeposit|港股大盘涨跌怎么计算？港股大盘涨跌幅度和走势预测
Next: cryptosoccernft| Bank of Beijing: The number of personal pension fund accounts exceeded 1.3 million, making it the first city commercial bank to exceed one million